InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Climb Bio, Inc.

CLYM Clue Score37
United States Fiscal year ends December CIK 0001768446 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

45
Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
40,000
$1.29
$51.60K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$7.89
$78.90K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$3.00
$30.00K
Ra Capital Management, L.p.
28 Sep 2026
Director
Exercised, kept indirect
10,000
$3.46
$34.60K
Stephen Basil Thomas
15 Sep 2026
Director
Sold on a plan
100,000
$13.67
$1.37M
Aoife Brennan
29 Jun 2026
President and CEO
Sold on a plan
30,902
$13.17
$406.98K
Stephen Basil Thomas
26 Feb 2026
Director
Sold on a plan
16,313
$7.01
$114.29K
Stephen Basil Thomas
25 Feb 2026
Director
Sold on a plan
33,687
$7.00
$235.96K
Stephen Basil Thomas
13 Feb 2026
Director
Sold on a plan
10,000
$5.81
$58.14K
Stephen Basil Thomas
12 Feb 2026
Director
Sold on a plan
90,000
$5.23
$470.99K
Ra Capital Management, L.p.
5 Jan 2026
Director
Buy indirect
7,111
$3.50
$24.89K
Ra Capital Management, L.p.
12 Dec 2025
Director
Buy indirect
101,462
$2.86
$290.18K
Ra Capital Management, L.p.
11 Dec 2025
Director
Buy indirect
213,099
$2.18
$464.56K
Aoife Brennan
30 Jun 2025
President and CEO
Sold on a plan
20,618
$1.22
$25.15K
Emily Pimblett
20 Jun 2025
SVP, Finance & CAO
Sold on a plan
1,242
$1.24
$1.54K
Emily Pimblett
20 Mar 2025
SVP, Finance & CAO
Sold on a plan
1,199
$1.31
$1.57K
Emily Pimblett
19 Dec 2024
Chief Accounting Officer
Sold on a plan
1,235
$2.02
$2.49K
Emily Pimblett
20 Sep 2024
Chief Accounting Officer
Sold on a plan
9
$8.06
$72.54
Emily Pimblett
20 Sep 2024
Chief Accounting Officer
Sold on a plan
1,182
$8.18
$9.67K
Valerie Morisset
22 Jul 2024
EVP, R&D and CSO
Sell
30,000
$7.98
$239.40K
Valerie Morisset
22 Jul 2024
EVP, R&D and CSO
Sell
39,005
$8.07
$314.77K
Valerie Morisset
19 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.24
$362.00K
Valerie Morisset
19 Jul 2024
EVP, R&D and CSO
Sell
10,201
$7.09
$72.33K
Valerie Morisset
18 Jul 2024
EVP, R&D and CSO
Sell
38,576
$6.93
$267.33K
Valerie Morisset
17 Jul 2024
EVP, R&D and CSO
Sell
3,207
$6.91
$22.16K
Valerie Morisset
16 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.13
$356.50K
Valerie Morisset
15 Jul 2024
EVP, R&D and CSO
Sell
42,377
$7.01
$297.06K
Valerie Morisset
12 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.07
$353.50K
Valerie Morisset
11 Jul 2024
EVP, R&D and CSO
Sell
50,000
$7.11
$355.50K
Valerie Morisset
10 Jul 2024
EVP, R&D and CSO
Sell
50,000
$6.83
$341.50K
Valerie Morisset
9 Jul 2024
EVP, R&D and CSO
Sell
5,931
$6.66
$39.50K
Valerie Morisset
5 Jul 2024
EVP, R&D and CSO
Sell
12,342
$7.06
$87.13K
Valerie Morisset
3 Jul 2024
EVP, R&D and CSO
Sell
50,000
$6.76
$338.00K
Valerie Morisset
1 Jul 2024
EVP, R&D and CSO
Exercised, kept
7,649
$0.00
$1.53
Ra Capital Management, L.p.
27 Jun 2024
Director
Buy indirect
1,059,375
$3.84
$4.07M
Ra Capital Management, L.p.
27 Jun 2024
Director
Buy indirect
11,949,171
$3.84
$45.88M
Emily Pimblett
20 Jun 2024
Chief Accounting Officer
Sell
1,245
$7.21
$8.98K
Valerie Morisset
5 Apr 2024
EVP, R&D and CSO
Exercised, kept
17,847
$0.00
$3.57
Valerie Morisset
20 Sep 2023
EVP, R&D and CSO
Exercised, kept
15,297
$0.00
$3.06
Valerie Morisset
20 Sep 2023
EVP, R&D and CSO
Exercised, kept
5,431
$0.00
$10.86
Valerie Morisset
10 Mar 2023
EVP, R&D and CSO
Exercised, kept
61,191
$0.00
$12.24
Valerie Morisset
10 Mar 2023
EVP, R&D and CSO
Exercised, kept
255,219
$0.00
$510.44
Ai Eti LLC
12 Aug 2021
10% owner
Buy
800,000
$12.50
$10.00M
Ra Capital Management, L.p.
12 Aug 2021
Director
Buy indirect
195,218
$12.50
$2.44M
Ra Capital Management, L.p.
12 Aug 2021
Director
Buy indirect
3,004,782
$12.50
$37.56M

What was left out

Form 4 filings counted 96
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,676,580
History held since 11 Aug 2021